Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat (abst - 2010) http/www.ncbi.nlm.nih.gov/pubmed/19515121
Up in smoke: 'Cannabis gave me my life back' (anecdotal – 2010) http/www.independent.co.uk/life-style/health-and-families/features/up-in-smoke-cannabis-gave-me-mylife-back-2041640.html
Effects of anandamide in migraine: data from an animal model. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3072518/
Migraines, Marijuana, and Chocolate (article – 2011) http/www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/22077199
Hallucinogens and cannabinoids for headache. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23030539
Use of cannabis among 139 cluster headache sufferers. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23197349
Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22670561?dopt=Abstract
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and "Triptan" Receptors: Implications in Migraine. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of Cannabinoid Receptor Activation on Spreading Depression. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http/www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-ofmarijuana/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014) http/www.thejournalofheadacheandpain.com/content/pdf/1129-2377-15-14.pdf
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24462931
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24977967
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (abst – 2014) http/cep.sagepub.com/content/34/9/686.abstract
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25191852
Exposure to Bisphenol A Exacerbates Migraine-Like Behaviors in a Multibehavior Model of Rat Migraine (abst – 2014)http://toxsci.oxfordjournals.org/con...3-0c57afd8aea8
Considering Marijuana Legalization (free e-book- link to download – 2015) http://www.rand.org/pubs/research_reports/RR864.html
Effects of peripheral FAAH blockade on NTG-induced hyperalgesia-evaluation of URB937 in an animal model of migraine (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25608877
Up in smoke: 'Cannabis gave me my life back' (anecdotal – 2010) http/www.independent.co.uk/life-style/health-and-families/features/up-in-smoke-cannabis-gave-me-mylife-back-2041640.html
Effects of anandamide in migraine: data from an animal model. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3072518/
Migraines, Marijuana, and Chocolate (article – 2011) http/www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/22077199
Hallucinogens and cannabinoids for headache. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23030539
Use of cannabis among 139 cluster headache sufferers. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23197349
Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22670561?dopt=Abstract
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and "Triptan" Receptors: Implications in Migraine. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of Cannabinoid Receptor Activation on Spreading Depression. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http/www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-ofmarijuana/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014) http/www.thejournalofheadacheandpain.com/content/pdf/1129-2377-15-14.pdf
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24462931
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24977967
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (abst – 2014) http/cep.sagepub.com/content/34/9/686.abstract
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25191852
Exposure to Bisphenol A Exacerbates Migraine-Like Behaviors in a Multibehavior Model of Rat Migraine (abst – 2014)http://toxsci.oxfordjournals.org/con...3-0c57afd8aea8
Considering Marijuana Legalization (free e-book- link to download – 2015) http://www.rand.org/pubs/research_reports/RR864.html
Effects of peripheral FAAH blockade on NTG-induced hyperalgesia-evaluation of URB937 in an animal model of migraine (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25608877